Innovate Corp

Innovate Corp (VATE) Stock Analysis

$7.590

-0.147 (-1.94%)At close

Loading chart…
High
7.950
Open
7.850
VWAP
7.71
Vol
50.04K
Mkt Cap
88.63M
Low
7.580
Amount
385.64K
EV/EBITDA, TTM
0.00

Innovate Corp. is a diversified holding company. The Company has a portfolio of subsidiaries in a variety of operating segments. Its segments include Infrastructure (DBMG), Life Sciences (Pansend), and Spectrum. The DBMG segment consists of DBM Global Inc., which is a fully integrated construction company offering both construction and professional services primarily through its core subsidiaries. It provides services, including design-assist, modularization, fabrication and erection of structural steel, heavy steel plate, trusses and girders, heavy equipment installation, as well as facility services for maintenance and shutdowns. Life Sciences segment consists of Pansend Life Sciences, LLC, which is focused on supporting healthcare and biotechnology product development. Spectrum segment consists of HC2 Broadcasting Holdings Inc. and its subsidiaries. It owns and operates broadcast television stations throughout the United States.

AI analysis of Innovate Corp (VATE)

hold

Innovate Corp (VATE) is currently priced at $7.59, which is significantly below its 52-week high of $21.30, indicating potential upside. However, the RSI is at 44.56, suggesting it is neither overbought nor oversold, and the forward P/E ratio is 4.86, indicating potential value. The main risk is the recent negative trend, with a 5-day change of -3.44%.

Valuation Metrics

The current forward P/E ratio for Innovate Corp (VATE) is 4.86, compared to its 5-year average forward P/E of -1.67.

Forward P/E

Strongly Overvalued
5Y Average P/E
-1.67
Current P/E
4.86
Overvalued
1.42
Undervalued
-4.75

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
42.28
Current EV/EBITDA
0.00
Overvalued
47.56
Undervalued
37.00

Forward P/S

Undervalued
5Y Average P/S
0.12
Current P/S
0.00
Overvalued
0.20
Undervalued
0.05

Events Timeline

2026-08-10 (ET)

11:00:00

Innovate Trading Halted, Volatility Trading Pause

09:00:00

INNOVATE Corp. Files $100M Mixed Securities Shelf

08:30:00

IES Holdings to Acquire DBM Global for $650M

2026-02-02 (ET)

09:00:00

INNOVATE Announces DBM Global to Pay $5M Cash Dividend

2025-12-16 (ET)

08:10:00

INNOVATE Announces MediBeacon FDA Approval for Next-Gen TGFRTM System

News

VATE FAQ — answered by Alphio AI

Innovate Corp. is a diversified holding company. The Company has a portfolio of subsidiaries in a variety of operating segments. Its segments include Infrastructure (DBMG), Life Sciences (Pansend), and Spectrum. The DBMG segment consists of DBM Global Inc., which is a fully integrated construction company offering both construction and professional services primarily through its core subsidiaries. It provides services, including design-assist, modularization, fabrication and erection of structural steel, heavy steel plate, trusses and girders, heavy equipment installation, as well as facility services for maintenance and shutdowns. Life Sciences segment consists of Pansend Life Sciences, LLC, which is focused on supporting healthcare and biotechnology product development. Spectrum segment consists of HC2 Broadcasting Holdings Inc. and its subsidiaries. It owns and operates broadcast television stations throughout the United States. It operates in the Industrials sector (FABRICATED STRUCTURAL METAL PRODUCTS industry).

Innovate Corp (VATE) is currently priced at $7.59, which is significantly below its 52-week high of $21.30, indicating potential upside. However, the RSI is at 44.56, suggesting it is neither overbought nor oversold, and the forward P/E ratio is 4.86, indicating potential value. The main risk is the recent negative trend, with a 5-day change of -3.44%.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started